women & heart disease grant - stage 1 › getmedia › 985bc... · please avoid the use of...
TRANSCRIPT
30/06/2020 Women & Heart Disease Grant - Page | 1
The purpose of this document is to guide applicants through the portal
application process for a Women & Heart Disease Grant.
For technical support, please refer to the Portal FAQ prior to contacting the Heart
Foundation or your institute.
Applications will only be accepted for eligibility review once the Research Office of an NHMRC Administering Institution
has endorsed the application.
Applicants must adhere to character and word limits where it is specified in the application (This is an eligibility criterion).
It is the responsibility of the applicant and the Research Administration Officer (RAO) to ensure that the application
is complete and accurate.
Applications must be endorsed by the Research Office of the Administering Institution and submitted online by 5pm
(AEST) on the closing date. Applications that are late, or do not adhere to the instructions/eligibility requirements will
not be considered further.
Applications must be submitted via the Heart Foundation’s Researcher Portal:
https://portal.heartfoundation.org.au/
On the Researcher Portal you will be able to login or register an account:
• If you have previously logged in, sign in as normal.
• If you are a first-time user, click on register.
• If you have previously applied for HF funding or regularly contact our Research Program with a specific email
address, please try and use that email address.
• If you are not in our system, you will be able to select a password and create an account.
• If you are in our system, it will recognise your email address and ask you to reset your password
Once logged on to the Researcher Portal, on the top right-hand side, click on Research > Apply Here, this will take
you to a list of current programs. Select the program you are applying to and you will be able to commence your
application.
Tips
• On each page, remember to click save & next as just navigating to a new page may mean you lose data.
• Once you submit, your RAO will be able to review and make comment on your application. You can resubmit
for review multiple times once the RAO has reviewed the application.
• Asterisk (*) denotes mandatory questions
Women & Heart Disease Grant - Stage 1
30/06/2020
Applicant Information
This information creates your contact record in our database and will pre-populate for all future applications. You can
update this information at any time in your profile section of the portal.
Applicant is used throughout this document. The term ‘applicant’ is used to define the primary applicant in the
application. Otherwise known as the ‘Chief Investigator A’
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Employer*:
Job Title*:
Position Start Date*:
FTE*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
Australian/NZ Citizen*:
Permanent Resident*:
LinkedIn:
Twitter URL:
Women & Heart Disease Grant - Page | 2
30/06/2020
Simplified Project Title*
• A simplified title is required for promotion of your research. Your simplified title should be suitable for release
to media and general publications. It will also be used as a straightforward way to identify the area in which
you are researching. Please avoid the use of technical terms, abbreviations, and acronyms.
• 100 character maximum
Scientific Project Title*
• The Scientific Title should accurately describe the nature of the project being undertaken.
• 300 character maximum
Research Category*
Project Synopsis*
• Your project synopsis will be used internally to promote your research, as well as for use in media releases. As
these audiences may not have technical backgrounds, we urge you to use lay terms when describing the
overall aims of the research and expected cardiovascular health outcomes.
• Try to avoid technical terms and acronyms.
• This project synopsis will be used on the Heart Foundation website if you are successful.
• 300 word maximum
Women & Heart Disease Grant - Page | 3
30/06/2020
Research Categories
• These categories are used by Heart Foundation staff to search for specific research – not included in review
process. Therefore, it should reflect the specifics of your research as opposed to areas that you hope your
research may reach.
• You will be able to choose 8 from a variety of categories.
Biology
Blood & Vessels
Blood Clotting
Brain and Nervous System
Cell Biology and Cell Signalling
Foetal Development
Genes
Heart Function and Structure
Hormones
Immune System
Inflammation
Kidneys
Lung Vasculature
Metabolic Processes
Molecules
Musculoskeletal System
Oxidative Stress
Prevention
Education
Food and Nutrition
Food Labelling
Health Promotion
Incentive Programs
Medication Adherence
Omega-3 Fatty Acids & Fish
Oils
Physical Activity/Exercise
Preventative
Device/Technology
Public Policy
Secondary Prevention
Smoking Cessation
Intervention
Vaccine
Lifestyle/Behaviour Change
Information & Technology
Computer Tools & Software
Smartphone App
SMS Messaging
Social Media
Telemedicine
Web based tools
Condition
Depression +/- Anxiety
Diabetes
Familial Hypercholesterolemia (
Fibrosis/Scar
Group A Streptococcal (GAS)
Diseases
Heart Attack - Acute Coronary
Syndrome
Heart Failure
Hypertension
Hypertrophy
Obesity
Peripheral Arterial Disease
Pulmonary Hypertension
Rheumatic Heart Disease
Statin Induced Myalgia
Stroke/Cerebrovascular
Disease
Sudden Cardiac Death
Thrombosis
Valvular Heart Disease
Liver Disease
Viral Infection
Treatment
Ablation
Care and Treatment Planning
Clot Busting
Cognitive/Behavioural Therapy
Fontan Procedure
Gene Therapies
Medication
Personalised Treatment
Rehabilitation
Remote Ischaemic
Preconditioning (RIPC)
Stem Cell Therapies
Stent Technology
Surgery
Transplant
Guidelines and Decision-
Making Tools
Service and/or Quality
Improvement
Devices
Transcatheter Procedure
CPR (cardiopulmonary
resuscitation)
Demographics
Aboriginal/Torres Strait Islander
Peoples
Ageing
Babies and Infants
Children and Adolescents
Indigenous Populations
Men
Rural/Remote
Urban
Women
Young Adults
Diagnostic & Assessment
Blood Flow Monitoring
Blood Tests
ECG (Electrocardiogram)
Genetic Screening
Imaging
Prediction
Risk Stratification
Stress Test
Risk Factors
Access to and Delay in
Treatment
Alcohol
Blood Pressure
Cholesterol and Plaques
Diet
Energy Drinks
Environmental Factors
Inherited Risk Factors/Genetics
Menopause
Mental Health
Pregnancy
Sedentary
Sleep and Sleep Disorders
Smoking
Socio-economic Factors
Weight
Salt
Other treatment/medication
Women & Heart Disease Grant - Page | 4
30/06/2020
Administering Institution Details*
• Select your Administering Institution from the menu.
• Please note your Administering Institute must be an NHMRC Administering Institution, an up to date list of
NHMRC Administering Institutions can be downloaded from the bottom of the NHMRC website.
• Before your application is submitted to the Heart Foundation, it is required to be endorsed by your administering
institute research office.
• If you have not already done so, it is important for you to contact their office to discuss your application, once
you select the institute, their contact email address will appear.
Women & Heart Disease Grant - Page | 5
30/06/2020 Women & Heart Disease Grant - Page | 6
Chief Investigators
• You are required to enter yourself in as a Chief Investigator A
• Title, Name, Email, Phone number, Role in Project, Institution and Position, Gender, Aboriginal or Torres Strait
Islander Descent, and CV.
• CV details entered in will retain formatting in rich text box.
• Only those individuals who contribute to the project in an important way should be included as Other Chief Investigators. Up to 10 investigators, including CIA, can be added.
• Other Chief Investigators are not required to endorse the application; however, the Heart Foundation expects
that the applicant (Chief Investigator A) will ensure Other Chief Investigators have reviewed the application and
will have sought their permission to include them on the application.
• 1000 word maximum for CV
• 500 character maximum for Role in Project
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 7
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 8
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 9
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 10
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 11
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 12
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 13
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 14
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 15
Salutation*:
First Name*:
Last Name*:
Email*:
Business Phone:
Mobile Phone*:
Job Title*:
Institution*:
Chief Investigator type*:
Role in Project*:
Gender*:
Aboriginal or Torres Strait Islander descent*:
CV* It is recommended a summary CV for each of the Chief Investigators, including their academic track record be
included. This is particularly important where the expertise of the Chief Investigators is crucial to the project:
30/06/2020 Women & Heart Disease Grant - Page | 16
Partnership Organisations
• All partnership organisations should be entered separately
• 500 character maximum for Role in Project
Organisation Name:
Organisation Status:
Organisation Location:
State:
ABN (if applicable):
Cash Support requested: $
Cash Support Status:
In-kind support requested: $
In-kind Support Status:
Please describe the partners role in project:
Organisation Name:
Organisation Status:
Organisation Location:
State:
ABN (if applicable):
Cash Support requested: $
Cash Support Status:
In-kind support requested: $
In-kind Support Status:
Please describe the partners role in project:
30/06/2020 Women & Heart Disease Grant - Page | 17
Organisation Name:
Organisation Status:
Organisation Location:
State:
ABN (if applicable):
Cash Support requested: $
Cash Support Status:
In-kind support requested: $
In-kind Support Status:
Please describe the partners role in project:
Organisation Name:
Organisation Status:
Organisation Location:
State:
ABN (if applicable):
Cash Support requested: $
Cash Support Status:
In-kind support requested: $
In-kind Support Status:
Please describe the partners role in project:
30/06/2020 Women & Heart Disease Grant - Page | 18
Organisation Name:
Organisation Status:
Organisation Location:
State:
ABN (if applicable):
Cash Support requested: $
Cash Support Status:
In-kind support requested: $
In-kind Support Status:
Please describe the partners role in project:
Organisation Name:
Organisation Status:
Organisation Location:
State:
ABN (if applicable):
Cash Support requested: $
Cash Support Status:
In-kind support requested: $
In-kind Support Status:
Please describe the partners role in project:
30/06/2020 Women & Heart Disease Grant - Page | 19
Ethics Approval
All ethics approvals and clearances necessary to complete the project outlined in the application must be in place
prior to funding being released to your Administering Institute. Whilst you are no longer required to submit
documentation, the Heart Foundation will conduct random audits with Institutes during the lifetime of an award. Should
it be found that ethics are not in place, all remaining funds will be withheld, and both the Researcher and the Institute
may receive multi-year bans on applying for Heart Foundation funding.
Is Ethics Required?
Yes No
Please select the ethic requirements associated with your research:
Animal Biosafety Human Other (Please Specify)
Other Ethics Type*
Budget Allocation
Budgets must be categorised by Personnel, Equipment, Maintenance and Other. You may only select a category
once and all details relating to that category should be included in that entry. Each total budget must not exceed
$1,000,000.
Budget Type* Personnel
Year 1 Year 2 Year 3
Total Personnel Budget
Budget Description*
Budget Type* Maintenance
Year 1 Year 2 Year 3
Total Maintenance Budget
Budget Description*
30/06/2020 Women & Heart Disease Grant - Page | 20
Budget Type* Equipment
Year 1 Year 2 Year 3
Total Equipment Budget
Budget Description*
Budget Type* Other
Year 1 Year 2 Year 3
Total Other Budget
Budget Description*
Total Year Budgets Annual Budgets will be paid quarterly
Year 1 Year 2 Year 3
Budget – Grand Total
30/06/2020 Women & Heart Disease Grant - Page | 21
Project Plan*
• This is your complete and detailed Research Plan.
• The section is limited to 1,500 words.
• Please see instructions in the portal for attaching graphics. Please note all image uploads must be clearly
labelled when corresponding to references in the proposed plan, for example: ‘Reference 1_Biomarkers’.
Where the project involves an intervention, describe the rationale for the intervention and how it will be evaluated.
Where applicable, include sample size and statistical power, sampling methods, main variables to be
measured/examined, methods of data collection, analysis and evaluation. Please specify timelines and major time
allocations
30/06/2020 Women & Heart Disease Grant - Page | 22
Submit for Endorsement
Once submitted, an email notification will be sent to the Research Office at your Administering Institution. Your
Research Office will review the application and either endorse it or return it for amendments. You will receive an email
notification advising of the status of this application only when your Research Office has endorsed or returned your
application.
If you or the Administering Institution do not receive email notifications, please check your spam folders and email
settings.
Certification
• I certify that all details provided in this application are correct and that I have read, understood, and have abided
by the instructions associated with this application
• I confirm that all applicable parties (including Head of Department, Supervisors, Referees and Other
Investigators) have reviewed and approved my application, and I have provided evidence of these approvals
and agreements to my Administering Institution's Research Office. I also confirm that all applicable parties have
read and understood the privacy statement.
• I agree to carry out the project in accordance with the principles of the Australian Code for the Responsible
Conduct of Research (2007). I acknowledge that all ethics approvals and clearances necessary to complete my
project as outlined in this application will be in place before commencement of the work.
• I acknowledge that all supporting documentation (ethic, citizenship, PhD documentation) has been provided to
my Administering Institution. I understand that the Heart Foundation may request this documentation at any time
throughout the duration of my funding.
• I confirm that I have complied with all instructions and understand that failure to do so may result in the
withdrawal of the application from the review process.
By submitting this form, I understand my application will be reviewed by my Administering Institution’ Research Officer
for endorsement and final submission to the Heart Foundation.
End of Application